Health In Tech, Inc.

Health In Tech, Inc. prepared an investor presentation to be used at conferences and meetings, highlighting its AI-powered marketplace platform for self-funded health plans. The company reaffirmed its 2026 revenue guidance of $45.0M to $50.0M and reported strong contracted and pipeline revenue. While Q2 2026 revenue and Adjusted EBITDA saw year-over-year declines, the presentation emphasized the company's scalable business model, lack of underwriting risk, and growth in distribution partners.

Health In Tech, Inc. reported Q2 2026 revenue of $8.1 million, a decrease from $9.3 million in Q2 2025, and a net loss of $2.5 million, compared to net income of $0.6 million in the prior year. Despite the decline in GAAP revenue and net income, the company saw its distribution partners grow by 19.9% year-over-year and reported $32.3 million in contracted revenue for the first half of 2026. Health In Tech reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million and announced progress on strategic initiatives, including securing its first employer group for the Three-Year Rate Stabilization Program and the upcoming launch of its HitRix platform.

Health In Tech, Inc. reported a net loss of $(2.51) million for Q2 2026, a significant decline from a $0.63 million net income in Q2 2025, with revenues decreasing to $8.06 million. For the six months ended June 30, 2026, the company posted a net loss of $(4.10) million, compared to a $1.13 million net income in the prior year. Despite the losses, the company completed a private investment in public equity (PIPE) financing, raising $5.92 million, and consolidated its new blockchain-enabled subsidiary, HITChain, from April 10, 2026.

Health In Tech, Inc. reported a net loss of $1.59 million for the three months ended March 31, 2026, a significant decline from a net income of $0.50 million in the prior year period, despite a 9.4% increase in total revenues to $8.77 million. The company also completed a private investment in public equity (PIPE) financing on March 27, 2026, raising net proceeds of $6.38 million by issuing 5,600,000 shares of Class A common stock. This financing boosted cash and cash equivalents to $10.33 million.

Health In Tech, Inc. hosted its first quarter 2026 earnings conference call, reporting Q1 revenue of $8.8 million, a 9% increase year-over-year, but a net loss of $1.6 million due to planned investments. The company reiterated its full-year 2026 revenue guidance of $45 million to $50 million, representing 35% to 50% year-over-year growth. Strategic investments are being made in sales distribution, technology development, and product offerings, including new KPIs like Contracted Revenue ($22.9 million for remaining 2026) and Platform Placed Plan Value ($82 million in Q1 2026).

Health In Tech, Inc. furnished an investor presentation for upcoming conferences and meetings. The presentation highlights the company's AI-powered marketplace platform, which helps small and medium-sized businesses access self-funded health plans. It details the company's business model, financial performance, and growth strategies, including 2026 revenue guidance of $45M-$50M, despite a negative Adjusted EBITDA in Q1 2026 due to growth investments.

Health In Tech, Inc. prepared an investor presentation for upcoming conferences and meetings, showcasing its AI-powered marketplace platform. The presentation highlights the company's role in enabling small and medium-sized businesses to access self-funded health plans, operating in an underserved market with a scalable, fee-driven business model. The company reiterated its 2026 revenue guidance of $45 million to $50 million, reflecting strong anticipated growth.

Health In Tech reported its first quarter 2026 financial results, with revenue increasing 9.4% to $8.8 million. However, the company posted a net loss of $1.6 million, or $(0.03) per diluted share, and Adjusted EBITDA of $(1.3) million, primarily due to increased sales and marketing investments for long-term growth. The company reiterated its full-year 2026 revenue guidance of $45 million to $50 million, citing strong demand for its AI-enabled platform and successful deployment of new features. Health In Tech also highlighted growth in distribution partners and a recent private investment in public equity financing to fund expansion initiatives.

Health In Tech, Inc. announced the departure of Dustin Plantholt from his role as Chief AI & Marketing Officer, effective April 30, 2026. This transition is part of a business restructuring and is not a result of any disagreement with the company. Following his departure, HITChain Inc., a subsidiary, entered into an independent contractor agreement with Plantholt Advisory Group LLC, owned by Mr. Plantholt. Under this agreement, the Consultant will receive monthly compensation, and Mr. Plantholt will be granted 500,000 restricted shares of HITChain common stock, vesting over twelve months.